Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Eradacil: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Eradacil - General Information

Eradacil is a quinolone derivative antibiotic for the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. Eradacil is known to be effective against penicillin resistant strains and is a single dose orally administered drug, which avoids all complications of parenteral administration seen with penicillin, especially anaphylactic shock.

 

Pharmacology of Eradacil

Eradacil is a nonfluorinated quinolone antibiotic. Its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Eradacil is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.

 

Additional information about Eradacil

Eradacil Indication

For the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients.

Mechanism Of Action
Eradacil binds to and inhibits the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.
Generic Name
Rosoxacin
Synonyms
ROS; Rosoxacino [Inn-Spanish]; Rosoxacine [Inn-French]; Acrosoxacin
Drug Category
Anti-Infective Agents
Drug Type
Small Molecule; Approved
Other Brand Names containing Rosoxacin
Eracine; Eradacil; Eradacin; Roxadyl; Winuron;
Chemical IUPAC Name
1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid
Chemical Formula
C17H14N2O3
Organisms Affected
Enteric bacteria and other eubacteria